John R Springer

John R Springer Email and Phone Number

Sr. Director, Pharmaceutical Development and R and D Project Management @ Confluence Discovery Technologies
St. Louis, MO, US
John R Springer's Location
St Louis, Missouri, United States, United States
John R Springer's Contact Details
About John R Springer

Confluence Discovery Technologies, Inc., based in St. Louis, is an independently wholly owned subsidiary of Aclaris Therapeutics, Inc. Aclaris (NASDAQ:ACRS) is a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs in dermatology, both aesthetic and medical, and immunology.

John R Springer's Current Company Details
Confluence Discovery Technologies

Confluence Discovery Technologies

View
Sr. Director, Pharmaceutical Development and R and D Project Management
St. Louis, MO, US
John R Springer Work Experience Details
  • Confluence Discovery Technologies
    Sr. Director, Pharmaceutical Development And R And D Project Management
    Confluence Discovery Technologies
    St. Louis, Mo, Us
  • Confluence Discovery Technologies
    Sr. Director, Pharmaceutical Development And R&D Project Management
    Confluence Discovery Technologies Oct 2022 - Present
    St Louis, Missouri
  • Confluence Discovery Technologies
    Director, Pharmaceutical Development And R&D Project Management
    Confluence Discovery Technologies Feb 2019 - Oct 2022
    St. Louis, Missouri
  • Confluence Discovery Technologies
    Sr. Project Manager, Sr. Principal Scientist, Pre-Clinical Development
    Confluence Discovery Technologies Jan 2018 - Feb 2019
    St. Louis, Missouri
  • Confluence Discovery Technologies
    Senior Principal Scientist, Manager-Chemistry Services
    Confluence Discovery Technologies Aug 2012 - Jan 2018
    St. Louis, Missouri
  • Confluence Discovery Technologies
    Principal Scientist
    Confluence Discovery Technologies Feb 2012 - Aug 2012
    St. Louis, Missouri
  • Maryville University
    Adjunct Faculty Instructor - Chemistry
    Maryville University 2011 - 2012
    Greater St. Louis Area
  • Pfizer
    Principal Scientist
    Pfizer Apr 2009 - Oct 2011
    Experienced Synthetic Organic Chemist/Medicinal Chemist utilizing modern techniques (singleton and library design) to develop/analyze/predict Structure Activity Relationships of small molecules, examine critically the physical properties/behaviors (PK/PD) of compounds and innovatively develop plans to successfully address compound related hurdles (ADME/TOX etc.). My ability to design/synthesize has resulted in clinical candidates. Concurrent research with large molecules (Proteins… Show more Experienced Synthetic Organic Chemist/Medicinal Chemist utilizing modern techniques (singleton and library design) to develop/analyze/predict Structure Activity Relationships of small molecules, examine critically the physical properties/behaviors (PK/PD) of compounds and innovatively develop plans to successfully address compound related hurdles (ADME/TOX etc.). My ability to design/synthesize has resulted in clinical candidates. Concurrent research with large molecules (Proteins, Antibodies), has led to innovative techniques for selective bioconjugation of active biological agents to large molecules. Manage workflow for 13 Discovery and 7 Scale Synthetic Chemists in Asian, Northern Europe, and Canadian research organizations significantly affecting the project by increasing new chemical entity production by 30% and delivering >60 kilograms of chemical intermediates and final compounds required to achieve targeted goals. [30-40 rolling requests, prioritization, timelines, raws sourcing, synthetic routes, and synthesis troubleshooting via weekly telecons].Excellence in synthetic organic chemistry via multi-step synthesis (singleton/library), small and large molecule synthesis (Macrocycles/Bioconjugation) and scale-up experienced performing 50mg to >1Kg reactions for chemistry optimization, method development, and route modifications enabling multi kilogram scale focused on reducing cost, number of synthetic steps, cycle time, and increasing scalability of synthesis.Minor Capital Committee Member. Developed relationships with vendors, researched new equipment, proposed/requested capital funding, and implemented installation/training of new equipment to ensure access to cutting-edge technology for all department chemists and maximize productivity. Show less
  • Pfizer
    Senior Scientist
    Pfizer Apr 2004 - Apr 2009
    Greater St. Louis Area
    Medicinal Chemist/synthetic organic chemist utilizing modern techniques (singleton and library design) to develop/analyze/predict structure activity relationships of small molecules, examine critically the physical properties/behaviors (PK/PD) of compounds and innovatively developed plans to successfully address compound related hurdles (ADME/TOX etc.).
  • Monsanto Company
    Scientist
    Monsanto Company Apr 2003 - Apr 2004
    St. Louis, Missouri
    Pharmacia - Medicinal Chemist/synthetic organic chemist utilizing modern techniques (singleton and library design) to develop/analyze/predict structure activity relationships of small molecules, examine critically the physical properties/behaviors (PK/PD) of compounds and innovatively developed plans to successfully address compound related hurdles (ADME/TOX etc.).
  • Monsanto Company
    Senior Associate Scientist
    Monsanto Company Jul 1999 - Apr 2001
    Greater St. Louis Area
    G.D. Searle Division - Medicinal Chemist/synthetic organic chemist utilizing modern techniques (singleton and library design) to develop/analyze/predict structure activity relationships of small molecules, examine critically the physical properties/behaviors (PK/PD) of compounds and innovatively developed plans to successfully address compound related hurdles (ADME/TOX etc.).
  • Monsanto Company
    Research Scientist
    Monsanto Company Oct 1997 - Jul 1999
    Greater St. Louis Area
    G.D.Searle (Pharmaceutical Kilo Prep Lab)• Synthesized chemical intermediates and final compounds for discovery chemists on kilogram scale from multi-step synthesis employing 22L jacketed glassware, high pressure 5 gal autoclave reactors, >300ml/min chromatographic equipment, and a variety of other large scale equipment. • Designed/conducted route improvements on gram scale as a pilot to reduce cost and synthetic steps, then transferred technology to multi kilogram… Show more G.D.Searle (Pharmaceutical Kilo Prep Lab)• Synthesized chemical intermediates and final compounds for discovery chemists on kilogram scale from multi-step synthesis employing 22L jacketed glassware, high pressure 5 gal autoclave reactors, >300ml/min chromatographic equipment, and a variety of other large scale equipment. • Designed/conducted route improvements on gram scale as a pilot to reduce cost and synthetic steps, then transferred technology to multi kilogram scale producing desired deliverables. Show less
  • Monsanto Company
    Associate Scientist
    Monsanto Company Jul 1997 - Oct 1997
    Greater St. Louis Area
    Agriculture Process Development - Conducted synthetic organic reactions, validated and initiated minor modifications to specific processes on the 1L and 22L scale to better understand untranslatable phenomena in pilot plant. Research efforts improved scalability to metric ton scale, resulting in significant cost savings to the manufacturing process of Clofencet (a wheat-hybridizing agent marketed as Genesis®).
  • Lewis And Clark Community College
    Chemistry Lecturer
    Lewis And Clark Community College May 1997 - Aug 1997
    Godfrey, Illinois
    Lectured chemical biology courses and accompanying laboratories.
  • Southern Illinois University Edwardsville
    Research Assistant
    Southern Illinois University Edwardsville Sep 1995 - May 1997
    Edwardsville, Illinois
    Synthesized carboranyl-modified fatty acids from decaborane for use in Boron Neutron Capture Therapy as a treatment for Cancer. Lectured and moderated introductory, organic, quantitative, and instrumental analysis laboratories. Organized and performed as chemistry tutor in tutor lab as well as exam grading and proctoring.

John R Springer Skills

Organic Chemistry Chemistry Chromatography Medicinal Chemistry Drug Discovery Analytical Chemistry Synthetic Organic Chemistry Drug Design Hplc R&d Lc Ms Purification Nmr Lead Change Structure Elucidation Drug Development Cmc Authorship Budget Management Ind Authorship Route Development

John R Springer Education Details

Frequently Asked Questions about John R Springer

What company does John R Springer work for?

John R Springer works for Confluence Discovery Technologies

What is John R Springer's role at the current company?

John R Springer's current role is Sr. Director, Pharmaceutical Development and R and D Project Management.

What is John R Springer's email address?

John R Springer's email address is jo****@****ail.com

What is John R Springer's direct phone number?

John R Springer's direct phone number is +151347*****

What schools did John R Springer attend?

John R Springer attended Maryville University Of Saint Louis, Southern Illinois University Edwardsville, Southern Illinois University Edwardsville.

What skills is John R Springer known for?

John R Springer has skills like Organic Chemistry, Chemistry, Chromatography, Medicinal Chemistry, Drug Discovery, Analytical Chemistry, Synthetic Organic Chemistry, Drug Design, Hplc, R&d, Lc Ms, Purification.

Not the John R Springer you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.